- Home
- NVCT vs RGC Comparison
NVCT vs RGC Comparison
Compare NVCT & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- RGC
- Stock Information
- Founded
- NVCT 2020
- RGC 2014
- Country
- NVCT United States
- RGC Hong Kong
- Employees
- NVCT N/A
- RGC N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- RGC Medicinal Chemicals and Botanical Products
- Sector
- NVCT Health Care
- RGC Health Care
- Exchange
- NVCT Nasdaq
- RGC Nasdaq
- Market Cap
- NVCT 119.4M
- RGC 105.3M
- IPO Year
- NVCT 2022
- RGC 2021
- Fundamental
- Price
- NVCT $4.90
- RGC $5.82
- Analyst Decision
- NVCT Strong Buy
- RGC
- Analyst Count
- NVCT 1
- RGC 0
- Target Price
- NVCT $21.00
- RGC N/A
- AVG Volume (30 Days)
- NVCT 303.6K
- RGC 241.7K
- Earning Date
- NVCT 11-05-2024
- RGC 11-29-2024
- Dividend Yield
- NVCT N/A
- RGC N/A
- EPS Growth
- NVCT N/A
- RGC N/A
- EPS
- NVCT N/A
- RGC N/A
- Revenue
- NVCT N/A
- RGC N/A
- Revenue This Year
- NVCT N/A
- RGC N/A
- Revenue Next Year
- NVCT N/A
- RGC N/A
- P/E Ratio
- NVCT N/A
- RGC N/A
- Revenue Growth
- NVCT N/A
- RGC N/A
- 52 Week Low
- NVCT $4.69
- RGC $3.03
- 52 Week High
- NVCT $12.10
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- NVCT 35.71
- RGC 45.73
- Support Level
- NVCT $4.75
- RGC $5.69
- Resistance Level
- NVCT $5.49
- RGC $6.71
- Average True Range (ATR)
- NVCT 1.14
- RGC 0.95
- MACD
- NVCT -0.52
- RGC -0.13
- Stochastic Oscillator
- NVCT 3.02
- RGC 7.31
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.